Trial Profile
Examination for the effect of combination therapy with alendronate and eldecalcitol in primary osteoporotic patients :A randomized active comparator study -Switch from alfacalcidol to eldecalcitol-
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2021
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Alfacalcidol (Primary) ; Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 02 Jan 2021 Status changed from recruiting to completed.
- 29 Dec 2011 New trial record